Cefonicid

DB01328ApprovedSmall molecule

A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft...

Chemical structure of Cefonicid
Mechanism
Curator reviewed
Primary indication
For the treatment of bacterial infections caused by susceptible microorganisms.Curator reviewed
Formula / weight
C18H18N6O8S3 · 542.566 g/mol (avg)

Resolves to

Structure
InChIKeyDYAIAHUQIPBDIP-AXAPSJFSSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O

What you can answer from here — as of September 13, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
800Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
126Marketed productsAcross 1 country and 59 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cefonicid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account